Center-Authored Papers

Filters: Author is Riddell, Stanley R  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Gardner R, Wu D, Cherian S, Fang M, Hanafi L-A, Finney O, Smithers H, Jensen MC, Riddell SR, Maloney DG et al..  2016.  Acquisition of a CD19-negative myeloid phenotype allows immune escape of MLL-rearranged B-ALL from CD19 CAR-T-cell therapy.. Blood. 127(20):2406-2410. Abstract
June CH, Riddell SR, Schumacher TN.  2015.  Adoptive cellular therapy: a race to the finish line.. Science translational medicine. 7(280):280ps7. Abstract
Till BG, Jensen MC, Wang J, Chen EY, Wood BL, Greisman HA, Qian X, James SE, Raubitschek A, Forman SJ et al..  2008.  Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells.. Blood. 112(6):2261-71. Abstract
Yee C, Thompson JA, Byrd D, Riddell SR, Roche P, Celis E, Greenberg PD.  2002.  Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells.. Proceedings of the National Academy of Sciences of the United States of America. 99(25):16168-73. Abstract
Riddell SR, Sommermeyer D, Berger C, Liu LS, Balakrishnan A, Salter A, Hudecek M, Maloney DG, Turtle CJ.  2014.  Adoptive therapy with chimeric antigen receptor-modified T cells of defined subset composition.. Cancer journal (Sudbury, Mass.). 20(2):141-4. Abstract
Berger C, Jensen MC, Lansdorp PM, Gough M, Elliott C, Riddell SR.  2008.  Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates.. The Journal of clinical investigation. 118(1):294-305. Abstract
Berger C, Turtle CJ, Jensen MC, Riddell SR.  2009.  Adoptive transfer of virus-specific and tumor-specific T cell immunity.. Current opinion in immunology. 21(2):224-32. Abstract
Balakrishnan A, Goodpaster T, Randolph-Habecker J, Hoffstrom BG, Jalikis FG, Koch LK, Berger C, Kosasih PL, Rajan A, Sommermeyer D et al..  2017.  Analysis of ROR1 protein expression in human cancer and normal tissues.. Clinical cancer research : an official journal of the American Association for Cancer Research. 23(12):3061-3071. Abstract
Wang Z, Storb R, Tapscott SJ, Riddell SR.  2012.  Analyzing Cellular Immunity to AAV in a Canine Model Using ELISPOT Assay.. Methods in molecular biology (Clifton, N.J.). 792:65-74. Abstract
Turtle CJ, Riddell SR.  2010.  Artificial antigen-presenting cells for use in adoptive immunotherapy.. Cancer journal (Sudbury, Mass.). 16(4):374-81. Abstract
Bleakley M, Turtle CJ, Riddell SR.  2012.  Augmentation of anti-tumor immunity by adoptive T-cell transfer after allogeneic hematopoietic stem cell transplantation.. Expert review of hematology. 5(4):409-25. Abstract
B
Hudecek M, Schmitt TM, Baskar S, Lupo-Stanghellini MT, Nishida T, Yamamoto TN, Bleakley M, Turtle CJ, Chang W-C, Greisman HA et al..  2010.  The B-cell tumor-associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptor.. Blood. 116(22):4532-41. Abstract
Salter AI, Riddell SR.  2015.  A BiTE from cancer's intracellular menu.. Nature biotechnology. 33(10):1040-1.
C
Tykodi SS, Fujii N, Vigneron N, Lu SM, Mito JK, Miranda MX, Chou J, Voong LN, Thompson JA, Sandmaier BM et al..  2008.  C19orf48 encodes a minor histocompatibility antigen recognized by CD8+ cytotoxic T cells from renal cell carcinoma patients.. Clinical cancer research : an official journal of the American Association for Cancer Research. 14(16):5260-9. Abstract
Turtle CJ, Hanafi L-A, Berger C, Gooley TA, Cherian S, Hudecek M, Sommermeyer D, Melville K, Pender B, Budiarto TM et al..  2016.  CD19 CAR-T cells of defined CD4+:CD8+ composition in adult B cell ALL patients.. The Journal of clinical investigation. 126(6):2123-38. Abstract
Turtle CJ, Riddell SR, Maloney DG.  2016.  CD19-Targeted chimeric antigen receptor-modified T-cell immunotherapy for B-cell malignancies.. Clinical pharmacology and therapeutics. 100(3):252-8. Abstract
Till BG, Jensen MC, Wang J, Qian X, Gopal AK, Maloney DG, Lindgren CG, Lin Y, Pagel JM, Budde LE et al..  2012.  CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial results.. Blood. 119(17):3940-50. Abstract
Wang J, Press OW, Lindgren CG, Greenberg P, Riddell S, Qian X, Laugen C, Raubitschek A, Forman SJ, Jensen MC.  2004.  Cellular immunotherapy for follicular lymphoma using genetically modified CD20-specific CD8+ cytotoxic T lymphocytes.. Molecular therapy : the journal of the American Society of Gene Therapy. 9(4):577-86. Abstract
Riddell SR, Jensen MC, June CH.  2012.  Chimeric Antigen Receptor Modified T Cells - Clinical Translation in Stem Cell Transplantation and Beyond.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
Sommermeyer D, Hudecek M, Kosasih PL, Gogishvili T, Maloney DG, Turtle CJ, Riddell SR.  2016.  Chimeric antigen receptor-modified T cells derived from defined CD8(+) and CD4(+) subsets confer superior antitumor reactivity in vivo.. Leukemia. 30(2):492-500. Abstract
Green ML, Leisenring WM, Xie H, Walter RB, Mielcarek M, Sandmaier BM, Riddell SR, Boeckh MJ.  2013.  CMV reactivation after allogeneic HCT and relapse risk: evidence for early protection in acute myeloid leukemia.. Blood. 122(7):1316-1324. Abstract
Salter AI, Liu LS, Riddell SR.  2014.  Combinatorial Antigen Recognition by Engineered T Cells. Journal of Investigative Medicine. 62:194-194. Abstract
Budde LE, Berger C, Lin Y, Wang J, Lin X, Frayo SE, Brouns SA, Spencer DM, Till BG, Jensen MC et al..  2013.  Combining a CD20 Chimeric Antigen Receptor and an Inducible Caspase 9 Suicide Switch to Improve the Efficacy and Safety of T Cell Adoptive Immunotherapy for Lymphoma.. PloS one. 8(12):e82742. Abstract
Robins HS, Campregher PV, Srivastava SK, Wacher A, Turtle CJ, Kahsai O, Riddell SR, Warren EH, Carlson CS.  2009.  Comprehensive assessment of T-cell receptor beta-chain diversity in alphabeta T cells.. Blood. 114(19):4099-107. Abstract
Groh V, Rhinehart R, Randolph-Habecker J, Topp MS, Riddell SR, Spies T.  2001.  Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells.. Nature immunology. 2(3):255-60. Abstract